JP Morgan Private Wealth Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,352
Closed -$221K 2078
2021
Q4
$221K Sell
5,352
-90
-2% -$3.98K ﹤0.01% 1872
2021
Q3
$253K Buy
5,442
+35
+0.6% +$1.53K ﹤0.01% 1764
2021
Q2
$216K Buy
5,407
+329
+6% +$14.1K ﹤0.01% 1811
2021
Q1
$273K Sell
5,078
-271
-5% -$15.6K ﹤0.01% 1571
2020
Q4
$262K Sell
5,349
-2,085
-28% -$96.6K ﹤0.01% 1553
2020
Q3
$242K Buy
+7,434
New +$236K ﹤0.01% 1450

Other funds holding VCYT

JP Morgan Private Wealth Advisors's VCYT Position: Q1 2022 in Review

JP Morgan Private Wealth Advisors sold out of Veracyte (VCYT) in Q1 2022, closing a stake of 5,352 shares — an estimated $221K sold.

JP Morgan Private Wealth Advisors first reported a position in VCYT in Q3 2020 and held it in 6 quarters. The position peaked at $273K in Q1 2021. 205 funds tracked by Wall St. Rank hold VCYT as of Q1 2022.

  • JP Morgan Private Wealth Advisors reported no remaining Veracyte position as of Q1 2022 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 5,352 Veracyte shares in Q1 2022, an estimated $221K.
  • JP Morgan Private Wealth Advisors first reported a position in Veracyte in Q3 2020 and held it in 6 quarters.
  • JP Morgan Private Wealth Advisors's Veracyte position peaked at $273K in Q1 2021.
  • 205 funds tracked by Wall St. Rank held Veracyte as of Q1 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q1 2022, filed 16 May 2022.